First, we aimed to validate the presence of TUSC3 methylation in CRC tissues, to study its prevalence and occurrence in the adenoma-carcinoma-sequence as well as putative associations with clinical factors. The gene discussed is TUSC3; the disease is colorectal carcinoma.